Drugs that contain Trypan Blue
1. Membraneblue patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6696430 | DORC | Use of vital dye for facilitating surgical procedures for vitreo-retinal surgery |
May, 2019
(5 years ago) | |
| US6372449 | DORC | Opthalmic methods and uses |
Nov, 2019
(4 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE) | Feb 20, 2016 |
Market Authorisation Date: 20 February, 2009
Treatment: Use of vital dye for facilitating surgical procedures for vitreo-retinal surgery; Use in identification of intraocular membranes to facilitate removal during ophthalmic surgery
Dosage: SOLUTION;OPHTHALMIC
More Information on Dosage
MEMBRANEBLUE family patents
2. Visionblue patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6720314 | DORC | Use of a vital dye for facilitating surgical procedures for cataract extraction |
May, 2019
(5 years ago) | |
| US6367480 | DORC | Methods for visualizing the anterior lens capsule of the human eye |
Oct, 2019
(4 years ago) | |
Market Authorisation Date: 16 December, 2004
Treatment: A method of applying trypan blue onto an outer surface of the anterior lens capsule to facilitate removal of the lens substance
Dosage: SOLUTION;OPHTHALMIC
More Information on Dosage
VISIONBLUE family patents